On this page
MCCC2
methylcrotonyl-CoA carboxylase subunit 2
The MCCC2 gene provides instructions for a subunit of an enzyme crucial for breaking down the amino acid leucine, playing a vital role in cellular energy production. The MCCC2 gene encodes the beta subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme, which is essential for processing proteins.
MCCC2 is located on the long (q) arm of chromosome 5, at band 5q13.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 5 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MCCC2 gene, also known as methylcrotonyl-CoA carboxylase subunit 2, is fundamental to cellular metabolism. It carries the genetic blueprint for one of the two subunits that form the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. This enzyme is crucial for the proper breakdown of proteins, specifically facilitating a key step in the metabolism of the amino acid leucine. Understanding MCCC2 is important for individuals undergoing carrier screening, particularly given its association with autosomal recessive conditions.
What the gene does
The MCCC2 gene directs the synthesis of the beta subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. This beta subunit combines with alpha subunits, encoded by the MCCC1 gene, to form the complete functional enzyme. The fully assembled MCC enzyme is located within the mitochondria, which are often referred to as the 'powerhouses' of the cell due to their role in energy generation. Its primary function involves the fourth step in the metabolic pathway of leucine, an essential amino acid derived from dietary protein. Specifically, MCC converts 3-methylcrotonyl-CoA into 3-methylglutaconyl-CoA, a molecule that is subsequently processed further for cellular energy. Proper functioning of this enzyme is therefore indispensable for efficient protein catabolism and overall metabolic health.
Video: Genetics 101
Chromosome location
The MCCC2 gene is situated on chromosome 5. Its specific location is at band 5q13.2. This genomic address pinpoints where the MCCC2 gene resides within the human genome, providing a precise reference for genetic studies and diagnostic purposes. The gene's position is consistent across individuals, though specific variants within this location can lead to altered protein function.
Protein structure
The MCCC2 gene encodes a protein consisting of 563 amino acids. This protein contains several distinct functional regions. The CoA carboxyltransferase N-terminal domain spans amino acids 49-306, while the CoA carboxyltransferase C-terminal domain is found between amino acids 309-555. The broader Carboxyltransferase region encompasses amino acids 49-555, reflecting the protein's enzymatic activity. Additionally, an Acyl-CoA binding region is located between amino acids 343-372, which is critical for its interaction with substrates during the metabolic process.
Key variants
Variants within the MCCC2 gene can alter the structure and function of the methylcrotonyl-CoA carboxylase beta subunit. These genetic changes can range from single nucleotide substitutions to larger deletions or insertions, potentially impacting the enzyme's ability to process leucine effectively. When these variants significantly reduce or abolish enzyme activity, they can lead to metabolic dysfunction.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.100C>T | p.Gln34Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1184_1192delinsGCATTTGAAGAAA | p.Asn395_Leu398delinsSerIleTer | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1208A>C | p.Asn403Thr | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1350T>A | p.Tyr450Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1371T>A | p.Tyr457Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1378A>T | p.Arg460Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1486C>T | p.Gln496Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1580G>A | p.Trp527Ter | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.1676G>A | p.Gly559Asp | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
c.231_232del | p.Gly79fs | Pathogenic/Likely pathogenic | ★★☆☆ | 3-methylcrotonyl-CoA carboxylase 2 deficiency |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MCCC2 gene are associated with an inherited metabolic disorder known as 3-methylcrotonyl-CoA carboxylase deficiency. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two affected copies of the gene (one from each parent) to develop the disorder. The deficiency impairs the body's ability to properly break down proteins, specifically the amino acid leucine, leading to a build-up of harmful metabolites.
Inheritance pattern
Conditions caused by pathogenic MCCC2 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The MCCC2 gene is recognised within several UK NHS clinical genomics panels. It is included in the DDG2P panel, the Intellectual disability panel, the Likely inborn error of metabolism panel (R98), and the Undiagnosed metabolic disorders panel, all of which are designated as 'green' status. This indicates that there is strong evidence for a gene-disease association and that the gene is routinely assessed in a clinical diagnostic setting for these conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the role of the MCCC2 gene?
The MCCC2 gene provides instructions for making the beta subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. This enzyme is crucial for breaking down the amino acid leucine, a vital step in cellular energy production.
What condition is associated with variants in the MCCC2 gene?
Variants in the MCCC2 gene are associated with 3-methylcrotonyl-CoA carboxylase deficiency. This is an autosomal recessive inherited disorder affecting the body's ability to process certain proteins.
How is 3-methylcrotonyl-CoA carboxylase deficiency inherited?
3-methylcrotonyl-CoA carboxylase deficiency follows an autosomal recessive inheritance pattern. This means an individual must inherit two altered copies of the MCCC2 gene, one from each parent, to develop the condition.
References
- Stadler SC, Polanetz R, Maier EM. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Human mutation. 2006. PMID: 16835865
- Dantas MF, Suormala T, Randolph A. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. Human mutation. 2005. PMID: 16010683
- Desviat LR, Pérez-Cerdá C, Pérez B. Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria. Molecular genetics and metabolism. 2003. PMID: 14680978
- Gallardo ME, Desviat LR, Rodríguez JM. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. American journal of human genetics. 2001. PMID: 11170888
- Baumgartner MR, Almashanu S, Suormala T. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. The Journal of clinical investigation. 2001. PMID: 11181649
- Holzinger A, Röschinger W, Lagler F. Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency. Human molecular genetics. 2001. PMID: 11406611